Beam Therapeutics Inc.

BEAM

$27.00

Name : Beam Therapeutics Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $2,731,374,592.00

EPSttm : -4.84

Beam Therapeutics Inc.

$27.00

7.44%

$1.87

Float Short %

27.93

Margin Of Safety %

Put/Call OI Ratio

0.5

EPS Next Q Diff

-0.06

EPS Last/This Y

0.28

EPS This/Next Y

-0.09

Price

Target Price

45.46

Analyst Recom

1.33

Performance Q

22.56

Relative Volume

0.95

Beta

2.4

Ticker: BEAM

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	BEAM	20.35	0.43	0.11	34789
2025-09-10	BEAM	19.89	0.43	0.50	34863
2025-09-11	BEAM	21.56	0.43	0.41	34688
2025-09-12	BEAM	20.61	0.43	0.13	34727
2025-09-15	BEAM	21.09	0.44	0.27	34117
2025-09-16	BEAM	22.91	0.43	0.18	34047
2025-09-17	BEAM	22.45	0.42308984047019	0.099254609650843	33898
2025-09-18	BEAM	25.11	0.43	0.10	33506
2025-09-19	BEAM	24.33	0.43	0.09	34204
2025-09-22	BEAM	24.41	0.45	0.60	18369
2025-09-23	BEAM	23.75	0.48	0.47	19210
2025-09-24	BEAM	23.61	0.49	0.50	19956
2025-09-25	BEAM	23.1	0.49	0.19	20173
2025-09-26	BEAM	22.93	0.49	0.61	20251
2025-09-29	BEAM	23.96	0.50	0.51	20287
2025-09-30	BEAM	24.29	0.51	0.25	21335
2025-10-01	BEAM	24.13	0.50	0.02	21550
2025-10-02	BEAM	25.59	0.50	0.06	21692
2025-10-03	BEAM	25.75	0.48	0.11	22170
2025-10-06	BEAM	25.86	0.49	0.19	22021
2025-10-07	BEAM	25.12	0.50	0.18	22042
2025-10-08	BEAM	27.01	0.50	0.05	22036
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	BEAM	20.35	12.8	-	-4.30
2025-09-10	BEAM	19.89	12.8	-	-4.30
2025-09-11	BEAM	21.55	12.8	-	-4.30
2025-09-12	BEAM	20.61	12.8	-	-4.30
2025-09-15	BEAM	21.29	12.8	-	-4.30
2025-09-16	BEAM	22.91	12.8	-	-4.30
2025-09-17	BEAM	22.48	12.8	-	-4.30
2025-09-18	BEAM	25.10	12.8	-	-4.30
2025-09-19	BEAM	24.33	12.8	-	-4.30
2025-09-22	BEAM	24.41	12.8	-	-4.30
2025-09-23	BEAM	23.75	12.8	-	-4.30
2025-09-24	BEAM	23.60	12.8	-	-4.30
2025-09-25	BEAM	23.09	12.8	-	-4.30
2025-09-26	BEAM	22.97	12.8	-	-4.30
2025-09-29	BEAM	23.91	12.8	-	-4.30
2025-09-30	BEAM	24.26	12.8	-	-4.30
2025-10-01	BEAM	24.14	12.8	-	-4.30
2025-10-02	BEAM	25.59	12.8	-	-4.30
2025-10-03	BEAM	25.75	12.8	-	-4.30
2025-10-06	BEAM	25.86	12.8	-	-4.30
2025-10-07	BEAM	25.14	12.8	-	-4.30
2025-10-08	BEAM	27.00	12.8	-	-4.30
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	BEAM	-1.27	-7.34	29.77
2025-09-10	BEAM	-1.27	-7.34	29.77
2025-09-11	BEAM	-1.27	-7.34	27.92
2025-09-12	BEAM	-1.27	-7.34	27.92
2025-09-15	BEAM	-1.27	-7.28	27.90
2025-09-16	BEAM	-1.27	-7.28	27.90
2025-09-17	BEAM	-1.27	-7.28	27.90
2025-09-18	BEAM	-1.27	-7.28	27.90
2025-09-19	BEAM	-1.27	-7.28	27.90
2025-09-22	BEAM	-1.27	-7.28	27.90
2025-09-23	BEAM	-1.27	-7.28	27.90
2025-09-24	BEAM	-1.27	-7.28	27.90
2025-09-25	BEAM	-1.27	-7.28	27.93
2025-09-26	BEAM	-1.27	-7.28	27.93
2025-09-29	BEAM	-1.27	-7.27	27.93
2025-09-30	BEAM	-1.27	-7.27	27.93
2025-10-01	BEAM	-1.27	-7.27	27.93
2025-10-02	BEAM	-1.27	-7.27	27.93
2025-10-03	BEAM	-1.77	-7.27	27.93
2025-10-06	BEAM	-1.01	-7.01	27.93
2025-10-07	BEAM	-1.01	-7.01	27.93
2025-10-08	BEAM	-1.01	-7.01	27.93
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-1

Avg. EPS Est. Current Quarter

-1.02

Avg. EPS Est. Next Quarter

-1.06

Insider Transactions

-1.01

Institutional Transactions

-7.01

Beta

2.4

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

80.5

Max Drawdown 5-Year %

-89.1

Target Price

45.46

P/E

Forward P/E

PEG

P/S

45.32

P/B

2.6

P/Free Cash Flow

EPS

-4.51

Average EPS Est. Cur. Y

-4.3

EPS Next Y. (Est.)

-4.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-661.31

Relative Volume

0.95

Return on Equity vs Sector %

-63.3

Return on Equity vs Industry %

-49.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Beam Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 509

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease; BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. It also intends to develop BEAM-103, an anti-CD117 monoclonal antibody, and BEAM-104, a cell therapy for development in sickle cell disease and beta-thalassemia; and BEAM-201 and other potential ex vivo CAR-T therapies. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

stock quote shares BEAM – Beam Therapeutics Inc. Stock Price stock today

news today BEAM – Beam Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BEAM – Beam Therapeutics Inc. yahoo finance google finance

stock history BEAM – Beam Therapeutics Inc. invest stock market

stock prices BEAM premarket after hours

ticker BEAM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BEAM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y